CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Predictive Factors of Event-Free Survival at 24 Months in Patients with Peripheral T-Cell Lymphoma: A Retrospective Study
Yu Ri Kim, Soo-Jeong Kim, Hye Sun Lee, Soyoung Jeon, Hyunsoo Cho, Haerim Chung, Ji Eun Jang, June-Won Cheong, Yoo Hong Min, Jin Seok Kim
Cancer Research and Treatment. 2022;54(2):613-620.   Published online 2021 August 5    DOI: https://doi.org/10.4143/crt.2021.270

Excel Download

Predictive Factors of Event-Free Survival at 24 Months in Patients with Peripheral T-Cell Lymphoma: A Retrospective Study
Cancer Research and Treatment. 2022;54(2):613-620   Crossref logo
Link1 Link2 Link3

Progression Free Survival at 24 Months in Patients with Diffuse Large B-Cell Lymphoma, an Argentinian Retrospective Cohort Study
Clinical Lymphoma Myeloma and Leukemia. 2018;18:S290-S291   Crossref logo
Link1 Link2

EVENT FREE SURVIVAL AT 12 MONTHS AND 24 MONTHS AS PREDICTORS FOR OUTCOME OF SYSTEMIC PERIPHERAL T CELL LYMPHOMA: ANALYSIS OF NATIONWIDE THAI LYMPHOMA STUDY GROUP
Hematological Oncology. 2019;37:277-278   Crossref logo
Link1 Link2

Age is the most important predictor of survival in diffuse large B‐cell lymphoma patients achieving event‐free survival at 24 months: a Swedish population‐based study
British Journal of Haematology. 2021;193(5):906-914   Crossref logo
Link1 Link2 Link3

Event free survival at 24 months is a strong surrogate prognostic endpoint of peripheral T cell lymphoma
Hematological Oncology. 2019;37(5):578-585   Crossref logo
Link1 Link2 Link3 Link4

A retrospective study of predictive factors for unexpectedly prolonged or shortened progression-free survival and overall survival among patients with metastatic renal cell carcinoma who received first-line targeted therapy
BMC Cancer. 2016;16(1):   Crossref logo
Link1 Link2 Link3 Link4

Prognostic value of event-free survival at 12 and 24 months and long-term mortality for non-Hodgkin follicular lymphoma patients: A study report from the Spanish Lymphoma Oncology Group
Cancer. 2017;123(19):3709-3716   Crossref logo
Link1 Link2

High Level of Serum Soluble Interleukin-2 Receptor Is Associated With Poor Survival in Patients With First Relapsed or Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified: A Retrospective Study
Clinical Lymphoma Myeloma and Leukemia. 2019;19(7):e337-e342   Crossref logo
Link1 Link2

Event free survival at 24 months: A new endpoint in diffuse large B-cell lymphoma
Annals of Oncology. 2017;28:v361   Crossref logo
Link1 Link2 Link3

Progression-free survival at 24 months (PFS24) and subsequent outcome for patients with diffuse large B-cell lymphoma (DLBCL) in the real-world setting
Annals of Oncology. 2019;30(1):151-152   Crossref logo
Link1 Link2 Link3

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.